128 related articles for article (PubMed ID: 20224770)
1. 60 kD Ro and nRNP A frequently initiate human lupus autoimmunity.
Heinlen LD; McClain MT; Ritterhouse LL; Bruner BF; Edgerton CC; Keith MP; James JA; Harley JB
PLoS One; 2010 Mar; 5(3):e9599. PubMed ID: 20224770
[TBL] [Abstract][Full Text] [Related]
2. Modification of lupus-associated 60-kDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading.
Scofield RH; Kurien BT; Ganick S; McClain MT; Pye Q; James JA; Schneider RI; Broyles RH; Bachmann M; Hensley K
Free Radic Biol Med; 2005 Mar; 38(6):719-28. PubMed ID: 15721982
[TBL] [Abstract][Full Text] [Related]
3. Selective small antigenic structures are capable of inducing widespread autoimmunity which closely mimics the humoral fine specificity of human SLE.
McClain MT; Scofield RH; Kurien BT; Gross TF; James JA
Scand J Immunol; 2002 Oct; 56(4):399-407. PubMed ID: 12234261
[TBL] [Abstract][Full Text] [Related]
4. A limited lupus anti-spliceosomal response targets a cross-reactive, proline-rich motif.
Arbuckle MR; Schilling AR; Harley JB; James JA
J Autoimmun; 1998 Oct; 11(5):431-8. PubMed ID: 9802926
[TBL] [Abstract][Full Text] [Related]
5. Structural availability influences the capacity of autoantigenic epitopes to induce a widespread lupus-like autoimmune response.
McClain MT; Lutz CS; Kaufman KM; Faig OZ; Gross TF; James JA
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3551-6. PubMed ID: 14988508
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to Ro/SS-A and La/SS-B in systemic lupus erythematosus and other autoimmune disorders.
Pradhan VD; Badakere SS; Bichile LS; Dolas MP
J Assoc Physicians India; 2002 Jun; 50():762-5. PubMed ID: 12240838
[TBL] [Abstract][Full Text] [Related]
7. Lupus humoral autoimmunity induced in a primate model by short peptide immunization.
Arbuckle MR; Gross T; Scofield RH; Hinshaw LB; Chang AC; Taylor FB; Harley JB; James JA
J Investig Med; 1998 Feb; 46(2):58-65. PubMed ID: 9549228
[TBL] [Abstract][Full Text] [Related]
8. Development of autoantibodies before the clinical onset of systemic lupus erythematosus.
Arbuckle MR; McClain MT; Rubertone MV; Scofield RH; Dennis GJ; James JA; Harley JB
N Engl J Med; 2003 Oct; 349(16):1526-33. PubMed ID: 14561795
[TBL] [Abstract][Full Text] [Related]
9. Human lupus anti-spliceosome A protein autoantibodies bind contiguous surface structures and segregate into two sequential epitope binding patterns.
James JA; Harley JB
J Immunol; 1996 May; 156(10):4018-26. PubMed ID: 8621944
[TBL] [Abstract][Full Text] [Related]
10. Early targets of nuclear RNP humoral autoimmunity in human systemic lupus erythematosus.
Poole BD; Schneider RI; Guthridge JM; Velte CA; Reichlin M; Harley JB; James JA
Arthritis Rheum; 2009 Mar; 60(3):848-59. PubMed ID: 19248110
[TBL] [Abstract][Full Text] [Related]
11. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry.
McClain MT; Heinlen LD; Dennis GJ; Roebuck J; Harley JB; James JA
Nat Med; 2005 Jan; 11(1):85-9. PubMed ID: 15619631
[TBL] [Abstract][Full Text] [Related]
12. Antineutrophil autoantibodies and their target antigens in systemic lupus erythematosus.
Chen M; Zhao MH; Zhang Y; Wang H
Lupus; 2004; 13(8):584-9. PubMed ID: 15462487
[TBL] [Abstract][Full Text] [Related]
13. Fine specificity of the Ro/SSA autoantibody response in relation to serological and clinical findings in 96 patients with self-reported cutaneous symptoms induced by the sun.
Popovic K; Brauner S; Ek M; Wahren-Herlenius M; Nyberg F
Lupus; 2007; 16(1):10-7. PubMed ID: 17283579
[TBL] [Abstract][Full Text] [Related]
14. Antibody against chromatin assembly factor-1 is a novel autoantibody specifically recognized in systemic lupus erythematosus.
Doe K; Nozawa K; Hiruma K; Yamada Y; Matsuki Y; Nakano S; Ogasawara M; Nakano H; Ikeda T; Ikegami T; Fujishiro M; Kawasaki M; Ikeda K; Amano H; Morimoto S; Ogawa H; Takamori K; Sekigawa I; Takasaki Y
Lupus; 2014 Sep; 23(10):1031-41. PubMed ID: 24836587
[TBL] [Abstract][Full Text] [Related]
15. Autoantibodies against the replication protein A complex in systemic lupus erythematosus and other autoimmune diseases.
Yamasaki Y; Narain S; Hernandez L; Barker T; Ikeda K; Segal MS; Richards HB; Chan EK; Reeves WH; Satoh M
Arthritis Res Ther; 2006; 8(4):R111. PubMed ID: 16846524
[TBL] [Abstract][Full Text] [Related]
16. Revisiting autoantibody profiles in systemic lupus erythematosus.
Olhoffer IH; Peng SL; Craft J
J Rheumatol; 1997 Feb; 24(2):297-302. PubMed ID: 9034986
[TBL] [Abstract][Full Text] [Related]
17. Survival impact of autoantibodies in systemic lupus erythematosus.
Gulko PS; Reveille JD; Koopman WJ; Burgard SL; Bartolucci AA; Alarcón GS
J Rheumatol; 1994 Feb; 21(2):224-8. PubMed ID: 8182629
[TBL] [Abstract][Full Text] [Related]
18. Reactivities to the Sm autoantigenic complex and the synthetic SmD1-aa83-119 peptide in systemic lupus erythematosus and other autoimmune diseases.
Jaekel HP; Klopsch T; Benkenstein B; Grobe N; Baldauf A; Schoessler W; Werle E
J Autoimmun; 2001 Dec; 17(4):347-54. PubMed ID: 11771960
[TBL] [Abstract][Full Text] [Related]
19. The curiously suspicious: a role for Epstein-Barr virus in lupus.
Harley JB; Harley IT; Guthridge JM; James JA
Lupus; 2006; 15(11):768-77. PubMed ID: 17153849
[TBL] [Abstract][Full Text] [Related]
20. Correlation between anti-Ro/La titers and clinical findings of patients with systemic lupus erythematosus.
Chien JW; Lin CY; Yang LY
Zhonghua Yi Xue Za Zhi (Taipei); 2001 May; 64(5):283-91. PubMed ID: 11499338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
